DAXOR CORP (DXR:NASDAQ)
$9.27 -0.13 (-1.383%)
Analysed DAXOR CORP (DXR:NASDAQ) News Sources
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
28-04-2026
yahoo.com
Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor
02-06-2026
yahoo.com
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
07-07-2026
yahoo.com
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
30-07-2026
yahoo.com
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
01-09-2026
yahoo.com
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
08-09-2026
yahoo.com
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
01-10-2026
yahoo.com
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
13-10-2026
yahoo.com
Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026
14-10-2026
yahoo.com
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
15-10-2026
yahoo.com
What is the current price of DAXOR CORP (DXR:NASDAQ)?
The current price of DAXOR CORP (DXR:NASDAQ) is $9.27.
DAXOR CORP (DXR:NASDAQ) absolute price change since previous trading day?
The absolute price change of DAXOR CORP (DXR:NASDAQ) since the previous trading day is $-0.13.
DAXOR CORP (DXR:NASDAQ) percentage price change since previous trading day?
The percentage price change of DAXOR CORP (DXR:NASDAQ) since the previous trading day is -1.383%.
What is the most recent average sentiment score for DAXOR CORP (DXR:NASDAQ)?
The most recent average sentiment score for DAXOR CORP (DXR:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for DAXOR CORP (DXR:NASDAQ)?
The most recent sentiment for DAXOR CORP (DXR:NASDAQ) is .
SEC-8K** Filing Available For DAXOR CORP (DXR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.